Oncolytic Virus Therapy Market 2018 Growth, COVID Impact, Trends Analysis Report 2023
Oncolytic virus therapy is based on the treatment through a virus that infects and kills cancer cells. These oncolytic viruses not only destroy the cancerous cell, also prevents the growth of tumour cells by stimulating the host anti-tumour immune responses. The first oncolytic virus therapy was approved in 2015, it is still is in the nascent stage of being considered as suitable and effective cancer therapy. The first oncolytic virus was the genetically modified herpes simplex virus type I that is Talimogene laherparepvec (T-VEC) that reported to be clinically beneficial for patients with melanoma.
Request a Free Sample of our Oncolytic Virus Therapy Market: https://www.omrglobal.com/request-sample/oncolytic-virus-therapy-market
Oncolytic virus therapy market is anticipated to grow at a decent growth rate during the forecast period. Most of the oncolytic virus therapy in clinical trials are in preclinical phase followed by Phase-I trials. At present, two three oncolytic drugs have been commercialised, however, approximately 48 oncolytic virus therapies are in clinical trials. The factors that are fuelling the growth of the market includes higher incidence and prevalence rate of cancer. Melanoma is one of the cancers that has been prevalent across the US region. The first oncolytic virus success over chemotherapy and radiotherapy have paved ways for developing them for other cancers. The other factors are the side effects associated with conventional cancer therapies. Chemotherapy and radiation therapy cause certain side-effects such as prolonged exposure to radiation may cause skin cancer.
A full Report of Oncolytic Virus Therapy Market is Available at: https://www.omrglobal.com/industry-reports/oncolytic-virus-therapy-market
Global oncolytic virus therapy market is segregated on the basis of the geographical regions that are contributing significantly towards the growth of the market. On the basis of the geography, market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America is the dominant market in the oncolytic virus immunotherapy market, globally. R&D in oncolytic virus therapy and cohesive government policies will boost innovative cancer therapies. Europe followed by APAC region are considered to be lucrative regions for the growth of oncolytic virus market owing to larger patient base and adoption for novel immunotherapies.
Oncolytic Virus Therapy Market Segmentation
By Product
- HSV-Based Oncolytic Viruses
- Adenoviruses-Based Oncolytic Viruses
- Vaccinia Virus-Based Oncolytic Viruses
- Vesicular Stomatitis Virus-Based Oncolytic Viruses
- Newcastle Disease Virus-Based Oncolytic Viruses
By Application
- Prostate Cancer
- Breast Cancer
- Ovarian Cancer
- Others
Competitive Landscape
Regional Analysis
- North American
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- ROE
- Asia Pacific
- India
- China
- Japan
- ROAPAC
- Rest of the World
Company Profiles
- Amgen
- BioVex Inc.,
- Cold Genesys, Inc.
- Crusade Laboratories
- Cynvec LLC
- Genelux Corp.
- JennerRex Co. Ltd
- Lokon Pharma AB
- MediGene AG
- Merck
- Neotropix, Inc.
- Oncolys BioPharma
- Oncolytics Biotech, Inc.
- Onyx
- Otsuka Pharmaceuticals Co. Ltd
- PsiOxus Therapeutics Ltd
- Roche
- Shanghai Sunway Biotech Co. Ltd
- Silajen Biotherapeutics, Inc.
- Sorrento Therapeutics
- SunWay Biotech Co. Ltd
- Takara Bio, Inc.
- Targovax
- Theravir
- TILT Biotherapeutics
- Transgene SA
- VCN Biosciences SL
- Viralytics Ltd
- Vyriad
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/oncolytic-virus-therapy-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment